Inside the Global Life Science Tools Market: Trends, Players & Strategic Signals

Explore the fast-evolving $180B+ life science tools space, from bioprocessing and diagnostics to genomic platforms and AI-powered research tools.

The life science tools market is not just growing—it’s evolving fast.
Valued at over $100 billion in 2023 and projected to surpass $180 billion by 2030, this space includes technologies that underpin everything from biologics manufacturing and cell therapy development to precision diagnostics and lab automation.

At its core, the market is driven by five powerful trends:

  • Demand for biopharma innovation (e.g., cell & gene therapy, ADCs, mRNA)
  • Rapid expansion of diagnostic and research labs worldwide
  • Increased use of automation, AI, and informatics in R&D
  • The decentralization of testing and analytics
  • Strategic M&A and platform consolidation by global players

Major players like Danaher, Thermo Fisher, Merck KGaA, Agilent, and Bio-Rad continue to expand their portfolios through both organic growth and acquisitions, while smaller innovators push forward in single-cell analysis, synthetic biology, and data platforms.

Table of life science tools companies and investors. Strategic resource for pharma execs, BD teams, and life science consultants
Scroll to Top